欧洲心脏移植市场预测至 2030 年 - 区域分析 - 按手术类型(原位心脏移植和异位心脏移植)、类型(供体活体心脏和人工心脏)和最终用户(医院、心脏中心等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 72    |    Report Code: BMIRE00030078    |    Category: Life Sciences

Europe Heart Transplant Market
预计到 2030 年,欧洲心脏移植市场规模将从 2022 年的 39.7032 亿美元增长至 87.8967 亿美元。预计从 2022 年到 2030 年,该市场的复合年增长率将达到 10.4%。

器官移植意识的提高推动了欧洲心脏移植市场的发展

在欧洲,提高心脏移植意识的努力包括教育活动、医疗保健提供者与器官采购组织之间的合作、立法举措以及医疗专业人员和组织的公共宣传。这些努力旨在让公众了解对心脏捐赠者的迫切需求,解决担忧或误解,并鼓励个人注册为器官捐赠者。此外,医疗技术和外科手术技术的进步促进了心脏移植的成功和可行性,进一步凸显了器官捐赠在拯救生命方面的重要性。因此,在欧洲国家,人们越来越接受和理解心脏移植作为终末期心力衰竭的治疗选择。

欧洲心脏移植市场概览

欧洲心脏移植市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。欧洲在全球心脏移植市场中占有重要地位,预计在 2022-2030 年期间将实现显着的复合年增长率。导致心力衰竭的心血管疾病的流行促进了该地区市场的增长。德国是一个有吸引力的市场,因为它在医疗保健领域持续增长并采取创新方法。根据联邦统计局的数据,2021 年德国的医疗支出达到 4740 亿美元。老年人口的增加和慢性病患病率的上升推动了该国心脏移植市场的增长。随着年龄的增长,许多器官开始出现故障或功能失调,从而需要进行器官移植手术。此外,根据世界卫生组织的数据,德国约有 40% 的死亡是由于行为风险因素造成的,包括饮食风险、吸烟、饮酒和缺乏身体活动。 2021 年,德国近 19% 的成年人肥胖。肥胖会引发各种其他健康问题。因此,肥胖和超重等导致慢性健康障碍的公共卫生问题可能会加剧德国对器官移植手术的需求。

德国的器官需求与器官捐赠之间存在差距。根据德国器官移植基金会 (DSO) 的数据,2021 年死后捐赠的器官共有 2,905 个,而需求为 8,730 个。因此,预计未来几年该国的器官移植手术将大幅增长。

欧洲心脏移植市场收入和预测到 2030 年(百万美元)

欧洲心脏移植市场细分

欧洲心脏移植市场细分为手术类型、类型、最终用户和国家。

根据手术类型,欧洲心脏移植市场分为原位心脏移植和异位心脏移植。 2022 年,原位心脏移植部分占据了欧洲心脏移植市场的更大份额。

就类型而言,欧洲心脏移植市场分为供体活体心脏和人工心脏。2022 年,供体活体心脏部分占据了欧洲心脏移植市场的更大份额。此外,人工心脏部分分为心室辅助装置和全人工心脏。

根据最终用户,欧洲心脏移植市场分为医院、心脏中心和其他。2022 年,医院部分占据了欧洲心脏移植市场的最大份额。

根据国家/地区,欧洲心脏移植市场分为德国、法国、英国、西班牙、意大利和欧洲其他地区。 2022 年,德国在欧洲心脏移植市场占据主导地位。

Terumo Corp、Abbott Laboratories、SynCardia Systems LLC、BioVentrix Inc、Berlin Heart GmbH、LivaNova Plc 和 Calon Cardio-Technology Ltd 是欧洲心脏移植市场的一些领先公司。

Europe Heart Transplant Strategic Insights

Strategic insights for Europe Heart Transplant involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-heart-transplant-market-strategic-framework.webp
Get more information on this report

Europe Heart Transplant Report Scope

Report Attribute Details
Market size in 2022 US$ 3,970.32 Million
Market Size by 2030 US$ 8,789.67 Million
Global CAGR (2022 - 2030) 10.4%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 手术类型
  • 原位心脏移植和异位心脏移植
By 类型
  • 供体活体心脏和人工心脏
By 最终用户
  • 医院
  • 心脏中心
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Terumo Corp
  • Abbott Laboratories
  • SynCardia Systems LLC
  • BioVentrix Inc
  • Berlin Heart GmbH
  • LivaNova Plc
  • Calon Cardio-Technology Ltd
  • Get more information on this report

    Europe Heart Transplant Regional Insights

    The regional scope of Europe Heart Transplant refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-heart-transplant-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Heart Transplant Market

    1. Terumo Corp

     

    2. Abbott Laboratories

    3. SynCardia Systems LLC

    4. BioVentrix Inc

    5. Berlin Heart GmbH

    6. LivaNova Plc

    7. Calon Cardio-Technology Ltd

     

    Frequently Asked Questions
    How big is the Europe Heart Transplant Market?

    The Europe Heart Transplant Market is valued at US$ 3,970.32 Million in 2022, it is projected to reach US$ 8,789.67 Million by 2030.

    What is the CAGR for Europe Heart Transplant Market by (2022 - 2030)?

    As per our report Europe Heart Transplant Market, the market size is valued at US$ 3,970.32 Million in 2022, projecting it to reach US$ 8,789.67 Million by 2030. This translates to a CAGR of approximately 10.4% during the forecast period.

    What segments are covered in this report?

    The Europe Heart Transplant Market report typically cover these key segments-

  • 手术类型 (原位心脏移植和异位心脏移植)
  • 类型 (供体活体心脏和人工心脏)
  • 最终用户 (医院, 心脏中心)
  • What is the historic period, base year, and forecast period taken for Europe Heart Transplant Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Heart Transplant Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Europe Heart Transplant Market?

    The Europe Heart Transplant Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Terumo Corp
  • Abbott Laboratories
  • SynCardia Systems LLC
  • BioVentrix Inc
  • Berlin Heart GmbH
  • LivaNova Plc
  • Calon Cardio-Technology Ltd
  • Who should buy this report?

    The Europe Heart Transplant Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Heart Transplant Market value chain can benefit from the information contained in a comprehensive market report.